This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Neil Soice - Innovator in Biopharmaceuticals
Introduction
Neil Soice is a prominent inventor based in Thousand Oaks, California. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody constructs. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Neil Soice holds a patent for "Downstream Processing of Bispecific Antibody Constructs." This patent highlights his focus on improving the efficiency and effectiveness of antibody production, which is crucial for therapeutic applications. He has 1 patent to his name, reflecting his commitment to innovation in this specialized area.
Career Highlights
Neil is currently employed at Amgen Inc., a leading biotechnology company known for its focus on human therapeutics. His role at Amgen allows him to work on cutting-edge projects that aim to enhance patient care through innovative biopharmaceutical solutions. His contributions to the field have positioned him as a valuable asset to the company and the industry at large.
Collaborations
Throughout his career, Neil has collaborated with talented professionals, including Pavel Bondarenko and Pik Chan. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Neil Soice is a dedicated inventor whose work in biopharmaceuticals continues to make a significant impact. His patent on bispecific antibody constructs exemplifies his innovative spirit and commitment to advancing medical science. Through his role at Amgen and collaborations with esteemed colleagues, he is poised to contribute further to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
